Vaccinia virus infection has been described as a method to obtain small quantities of proteins in HeLa S3 cultures 1, 2) and as a gene delivery vector. [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] Vaccinia virus has several features which might be beneficial in the production of large proteins with complex posttranslational modifications. The virus has a large genome, which allows for large recombinant gene inserts. It produces proteins in the cytoplasm of the infected cells, thus eliminating nuclear transport requirements.
13) It also uses the post-translational processing pathways of the host cells 14) where, when expressing proteins in human cells, more appropriate human processing can occur. To scale up the vaccinia virus expression method for the production of large amounts of recombinant proteins, evaluations of cell growth, infection, and protein production are required.
A recombinant vaccinia virus expressing intracellular enhanced green fluorescent protein (EGFP) controlled by the T7 promoter-based VOTE expression system 15) was constructed previously. 16) Infection of microcarrierattached HeLa cells grown in spinner flasks with the recombinant vaccinia virus produced 2.2 mg EGFP/10 6 cells at infection. 16) An optimization of several of the infection and process parameters such as inducer concentration, multiplicity of infection (MOI), dissolved oxygen (DO), and temperature led to an increase in production to about 17 mg EGFP/10 6 infected cells in spinner flask cultures. 17) Protein levels from bioreactors have been lower (e.g., 2-3 mg/10 6 cells for HIV gp160 and gp120 18, 19) ) so we were interested in making process modifications that would increase this yield.
To assess the potential of this system, growth strategies implementing hollow fiber perfusion and production parameters such as multiplicity of infection and temperature were evaluated. Medium replacement via perfusion can dramatically boost cell density and yield. [20] [21] [22] The MOI also plays an important role in expression. Interestingly, previous work has shown that the optimal MOI was different for tissue flask and microcarrier cultures. 16, 17) This was not unique to vaccinia; differences between tissue plate culture and suspension culture have been shown in baculovirus/ insect cell studies. 23) Further, lowered temperature during the protein production phase has been shown to be beneficial for both the Semliki Forest Virus expression system 24) and the vaccinia virus expression system in microcarrier based cultures. 17) This may have been due to a reduced cytopathic effect from the virus at y To whom correspondence should be addressed. Fax: +1-301-451-5911; E-mail: yossi@nih.gov Abbreviations: DMEM, Dulbecco's Modified Eagle's Medium; DO, dissolved oxygen; EGFP, enhanced green fluorescent protein; FBS, fetal bovine serum; hpi, hours post infection; IPTG, isopropyl--D-thiogalactopyranoside; MOI, multiplicity of infection (pfu/cell); VOTE, vaccinia virus/ lac operon/T7 RNA polymerase/EMC leader lowered temperatures, allowing the cells to remain intact and producing protein for a longer period of time, although this was not shown.
Several methods are available for perfusion of suspension culture, such as hollow fiber, spin filter, and acoustic filter. 25) The present viral expression method requires that the cell separation device enable rapid medium exchanges during the infection process, when the serum concentration and volume are reduced to create an effective infection environment. The hollow fiber system is relatively simple, requiring only a filter cartridge, tubing, and peristaltic pumps. Hollow fiber cartridges have been successfully used by other laboratories for perfusion of mammalian cell cultures, [20] [21] [22] and can handle large rates of exchange if sized properly. This report describes an evaluation of HeLa S3-vaccinia protein expression in hollow fiber perfusion culture.
Materials and Methods
Cell maintenance and expansion. HeLa S3 cells (ATCC CCL-2.2) were maintained in 200 ml spinner flasks in Dulbecco's Modified Eagle's Medium (DMEM, Biosource, Camarillo, CA) with 4.5 g/l glucose, without calcium, supplemented with 4 mM glutamine (Invitrogen, Carlsbad, CA) and 10% fetal bovine serum (FBS, Biosource). The cultures were passaged every 3-4 d, reducing the cell density to approximately 2 Â 10 5 cell/ml while retaining at least 10-20% conditioned medium in the new culture. Cultures were expanded into multiple 1,000 ml spinner flasks to obtain the number of cells needed for seeding bioreactor cultures.
Cell density and viability measurements. Samples of cell suspension were taken from cultures and a portion was diluted in PBS and mixed with 0.4% trypan blue solution (Sigma, St. Louis, MO) for viability staining. The stained solution was then counted using a hemacytometer to determine total cell density and viability.
Metabolite measurements. Glucose and lactate measurements were made on supernatant samples from spinner flask or bioreactor cultures using a YSI 2700 Biochemistry Analyzer (Yellow Springs Instrument, Yellow Springs, OH).
Spinner flask seeding and growth. Spinner flask cultures containing 200 ml of culture in 250 ml Bellco spinner flasks with stir bar and paddle (Bellco Glass, Vineland, NJ) were seeded with 1:0 Â 10 5 cell/ml. The agitation speed was set at 50 rpm in a humidified, 5% CO 2 , 37 C incubator. Cultures were monitored daily for cell density, viability, glucose, and lactate.
Suspension bioreactor seeding and growth. HeLa S3 cells were seeded into a 2.2-liter bioreactor (New Brunswick Scientific, New Brunswick, NJ) with a working volume of 1.5 liters using the same medium used for spinner flask culture with the addition of 100 units/ml Penicillin and 100 mg/ml Streptomycin (Invitrogen) to reduce the chance of contamination. Approximately 10-20% of the final reactor volume was conditioned culture medium from the seeding spinner flasks to ensure growth of the culture. Cells were seeded to a density of 2 Â 10 5 cell/ml and grown at 36.5 C, 30% DO based on air saturation at 36. 5 C, at pH 7.2. Perfusion feeding was achieved for this culture using a hollow fiber cartridge (A/G Technology, Needham, MA) with 0.45 mm pores and 1.0 mm inner diameter capillaries through which the culture flowed. The culture was circulated at a rate of about 15 reactor volumes per d and the medium exchanged up to 1.5 reactor volumes per d via level-controlled addition of fresh feed. Aeration was achieved through headspace gassing at 1.0 l/min until day 3-4, when it was switched to sparging into the culture at 0.3 l/min and 0.1% Pluronic F-68 was added to reduce foaming and shear effects. A schematic of the reactor setup is shown in Fig. 1 , which details the arrangement of reactor components and the hollow fiber perfusion unit. Samples were taken daily to determine cell density, viability, and glucose and lactate concentrations.
Virus preparation. Virus containing the gene for EGFP, vNB009, was constructed as described previously. 16) Briefly, a plasmid containing the gene for EGFP with a C-terminal 6 Â histadine tag was constructed. The EGFP and tag genes were then inserted into a recombinant vaccinia virus under the VOTE 15) control system and a viral stock was made. A portion of the viral stock was incubated 1:1 with 1 Â trypsin at 37 C for 30 min with vigorous vortexing every 10 min to break up clumps. This preparation was then used to infect the spinner flask or bioreactor culture at the appropriate MOI. Fluorescence measurement of EGFP. Fluorescence measurements were made as described previously. 16) Briefly, samples of cell pellet were resuspended and lysed in lysis buffer (100 mM Tris pH 7.4, with 1 Â Complete protease inhibitor (Roche Diagnostics, Indianapolis, IN) and 0.5% Triton X-100). Fluorescence measurements of the resulting supernatant from pellet lysis and separate samples of culture medium were made in 96-well black plates (Fisher Scientific, Pittsburg, PA) using a SpectraMax Gemini fluorescence spectrophotometer (Molecular Devices, Sunnyvale, CA) with excitation at 485 nm, emission at 512 nm, and an auto cutoff filter of 495 nm against standards of rEGFP (Clontech BD Biosciences, Palo Alto, CA) in either lysis buffer or fresh medium, respectively.
Infection. Spinner flask cultures of HeLa S3 cells in exponential phase were mixed to obtain a uniform population for infection experiments. 20 Â 10 6 cells were centrifuged at 300 Â g for 5 min for each experimental condition. The cells were resuspended in approximately 20 ml of their conditioned medium. They were transferred to fresh Bellco 250 ml spinner flasks with stir bar and paddle. The medium was brought to 70 ml with serum-free medium, and inducer was added to 1.0 mM IPTG. Virus vNB009 was added to infect at the appropriate MOI and the flasks were returned to the incubator for 1 h of infection. The medium was then brought up to 200 ml with 10% FBS and 1.0 mM IPTG. The cultures were incubated and samples taken daily for cell count, viability, glucose, lactate, and protein determination. Feeding was performed to keep glucose above 1.0 g/l and lactate below 2.0 g/l at either 24 hpi or both 24 and 48 hpi by centrifuging half of the culture at 300 Â g for 5 min to pellet the cells, aspirating the medium and resuspending them in fresh medium with IPTG. This mixture was then returned to the spinner flask and the culture was incubated.
Production in bioreactors. Five days after seeding 2 Â 10 5 cell/ml into the bioreactor, viable cell density measurement was made on the culture to determine the total number of cells. Medium without serum or Pluronic F-68 but containing 1.0 mM IPTG was connected to the reactor through the feed addition pump. A hollow fiber cartridge was used to perform exchange of the culture supernatant to this serum-free induction medium and to reduce the volume in the reactor to about 400 ml. This exchange and reduction process took about 5 h to perform. Trypsinized virus vNB009 was diluted in 100 ml of serum-free medium and added to the reactor to infect at an MOI of 1.0. The infection phase lasted 1 h in this reduced serum and volume environment, after which the medium volume was brought back to 1.5 liters and serum and Pluronic F-68 were reintroduced to 10% and 0.1% respectively. The temperature and DO setpoints were also adjusted at this time to either 34 C or 36. 5 C and 50%, respectively. The culture was gradually fed using the hollow fiber for exchange and level control for addition of 1 liter of media between 24 and 48 hpi. Samples were taken periodically and analyzed for glucose, lactate, cell density, viability, and recombinant protein expression.
Results
Effect of MOI on EGFP production with suspension HeLa S3 cells
As noted above, the effects of MOI depend on the reactor scale and configuration. Here, evaluation of MOI on the recombinant protein yield was performed in spinner flasks. Cultures Effect of temperature on EGFP expression in HeLa S3 suspension culture
Lowering the culture temperature in a viral expression system has often been explored to increase the protein yield. Here, we evaluated temperature reduction in spinner flask cultures containing 10 6 HeLa S3 cells/ml infected at an MOI of 1.0 with the recombinant virus carrying the EGFP reporter gene. After infection, the flasks were incubated at 25, 28, 31, 34, and 37 C AE 0:5 C (the 37 C culture results were taken from the previous MOI experiment at MOI 1.0), and the intracellular EGFP levels were determined. The expression profiles are shown in Fig. 3A . Maximum EGFP levels were seen with 34 C around 44 hpi, 31 C around 52 hpi, and 28 C around 96 hpi. The EGFP levels achieved were 3:3 AE 0:13, 2:6 AE 0:36, and 3:4 AE 0:29 mg/10 6 infected cells respectively, all within error of each other, P ! 0:057. All three of these temperatures resulted in maximum EGFP levels above 37 C and 25 C with statistical significance, P 0:0065. The percent viability is plotted in Fig. 3B , which shows that 25 C and 28 C maintained higher cell viabilities than temperatures above 30 C.
Perfusion growth of HeLa S3 suspension cells
The growth profile of HeLa S3 suspension cells was determined by growing the cells using the perfusion mode in a bioreactor equipped with a hollow fiber membrane cartridge. The total cell density and the percent viability are shown in Fig. 4 . Exponential growth of the HeLa S3 cells was maintained for about 7 d in this system with a maximum viable cell density of 1:3 Â 10 7 cells/ml.
Production of EGFP in HeLa S3 suspension bioreactor with hollow fiber perfusion EGFP was produced in perfused HeLa S3 bioreactor culture under the conditions determined above for the MOI and temperature and compared to a single production run at 36.5 C. The results for the runs at 34 C are shown in Fig. 5A to C, and the comparison of expression in Fig. 6 . Infection was performed in the bioreactor at a cell concentration of 2:7 AE 0:57 Â 10 6 cell/ml, using an MOI of 1.0 and adjusting the temperature during production to either 34 C or 36.5 C. Figure 5A to C describes the overall production process at 34 C with the online parameters for a typical production run in 5A, the average glucose and lactate values in 5B, and the average total cell density and percent viability in 5C. Intracellular and extracellular levels of EGFP are shown in Fig. 6 for both temperatures. The maximum intracellular EGFP Total cell density (open circle) and percent viability (solid circle) are plotted over the course of a single bioreactor run growing HeLa S3 suspension cells while utilizing a hollow fiber cartridge for perfusion of the culture. The error in measurement was less than 12% for total cell density, except for one anomalous measurement at 189 h with 27%, and 2.5% for viability.
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was achieved for the production run at 34 C, about 120 hpi at 9:9 AE 0:82 mg/10 6 infected cells, which is higher than the level obtained at 36.5 C (at 3.5 mg/10 6 infected cells). This maximum at 34 C corresponds to an overall production of 27 mg/l. In both cases, the intracellular level of EGFP dropped after reaching the maximum value, and the extracellular concentration increased over time.
Discussion
Vaccinia virus infection of HeLa S3 cells has been used to produce small quantities of proteins in spinner flask cultures. 1, 2) The scale-up of this process required an examination of process parameters such as multiplicity of infection, temperature, and cell density. Multiplicity of infection, in other viral systems, has been shown to affect protein yield. [26] [27] [28] In this study, the optimum MOI using primary infection was found to be 1.0, indicating that only one infectious virus particle per cell was needed to achieve maximum expression. This was less than the MOI of 5.0 that was found optimum for the anchorage dependent HeLa cell line in microcarrier based culture. 17) Therefore, the infection kinetics of the cell suspension based system differed from those of the microcarrier based system. A similar phenomenon has been described for baculovirus infection where suspension cultures had higher attachment rates for the virus than monolayer cultures. 23, 29) Additionally, in this case, MOIs of 5.0 and 10.0 appeared to increase cell death over MOI 1.0, as indicated by the slightly lower viable cell densities reported at 24 and 48 hpi. These lower viable cell densities might partially explain the lower expression at these higher MOIs. It is also important to note that these studies were carried out with the aim of synchronous, primary infection. It might be possible to obtain higher levels of expression through secondary infection by using a lower MOI, but the cell density at infection would likely need to be lowered in order to supply nutrients and remove wastes from the higher density culture that would result from a portion of the cells continuing to grow during the early stages of the infection phase.
In addition to evaluating MOI, several researchers have modeled virus systems to gain an understanding of the factors affecting the viral infection processes. Dee et al. cells which can be generalized to other acid-dependent enveloped viruses. They found that binding of the virus to the cell receptor was the rate-limiting step. Chillakuru modeled the infection of vaccinia virus, and found that the ionic composition of the medium and the presence of serum proteins played an important role in adsorption kinetics, and that cells infected during the exponential phase yielded more virus particles than those infected in the lag or stationary phase. 30) These results suggest that parameters such as medium composition might affect protein expression via the amount of virus binding, indicating that these parameters need to be carefully considered when scaling up.
Of particular importance to a viral infection system is the achievement of high cell density of exponentially growing cells, which can increase the volumetric productivity. It is important to have healthy, exponentially growing cells for efficient infection with vaccinia virus. 30) A hollow fiber perfusion method was implemented to generate high cell density cultures and to perform the serum-free media replacement and volume reduction needed for efficient infection. The maximum viable cell density reached for HeLa S3 cells grown in a bioreactor, using perfusion via hollow fiber, was 1:3 Â 10 7 cell/ml, several times higher than what was achieved in batch spinner flask culture. This increase in maximum cell density was accompanied by an exponential growth phase of about 7 d. The growth profile provided a time frame from approximately 100 to 175 hours post seeding to infect the cells. The medium manipulations required prior to infection, to reduce the serum concentration and lower the volume in the reactor while maintaining the total number of cells, was easily performed with the hollow fiber and could be scaled up.
Lowering culture temperature in viral systems has been shown to increase protein yield, most likely due to a decrease in the cytopathic effect. A temperature of 34 C in the Semliki Forest Virus (SFV) system, 24) and of 31 C in the microcarrier based vaccinia system, 17) increased protein production compared to the 37 C cultures in each system. With the HeLa S3 suspension cells it was found that cultures grown at 28 C after infection produced the largest amount of intracellular EGFP, within error of 31 C and 34 C, but because this level of production was reached much later, a temperature of 34 C after the infection phase was used for further experiments. Additionally, the viability of the cultures decreased more rapidly for temperatures above 30 C than for those below, indicating a decreased cytopathic effect at lower temperatures, thus leading to slower cell death. It is also possible that because the experiments were performed in spinner flasks, the lower temperature affected the level of dissolved gases such as oxygen and carbon dioxide and thereby changed the culture pH. Without isolating temperature as the only adjusted parameter, it is likely that the results obtained from the spinner flasks were not due to temperature alone. EGFP reporter protein was produced in 1.5-liter bioreactor culture using the conditions defined by the spinner flask infection experiments and the growth profile of HeLa S3 using hollow fiber perfusion feeding. The expression results indicate that the production of EGFP in this perfusion based suspension system attained 9:9 AE 0:82 mg/10 6 infected cells. This was three times the level seen when the production temperature was maintained at 36.5 C. It is also important to note that the maximum level of expression in the bioreactor system occurred 50-60 h later than the spinner culture at the same temperature, possibly due to the controlled environment and the cells' physiological state. The dramatic increase in production at lowered temperature in bioreactor cultures, where temperature was controlled separately from dissolved gases, indicates that temperature plays a significant role in protein yield with this expression method.
The results of this study indicate that we were able to significantly increase cell density by utilizing perfusion culture prior to infection. Application of various process changes, MOI and temperature, also led to increased specific protein production. The combination of these process changes resulted in approximately 27 mg/l EGFP versus about 3.4 mg/l in the best-case spinner flask culture. These large differences in culture productivity might be due to limiting culture conditions in the spinner flasks, such as nutrient supply or aeration, versus the perfused bioreactor. Additionally, production in this system surpassed previous work in microcarrier-based spinner flasks where production reached only approximately 15 mg/l.
17)
Conclusions
The HeLa S3-vaccinia virus expression system has been used for research purposes to make small quantities of proteins. Through an investigation of some key parameters and evaluation of a hollow fiber perfusion method in order to increase cell density, the production capacity of this expression method was increased to the bioreactor scale at 1.5 liters, and theoretically could be scaled further with increased reactor and hollow fiber cartridge size. This system could be further optimized for production purposes by altering other process parameters, such as pH, or altering medium components. These results provide a starting point for further process improvements to this method of laboratory to pilot scale protein production.
